Cinepazide

CAS NO.：23887-46-9
Empirical Formula: C22H31N3O5
Molecular Weight: 417.5
MDL number: MFCD00868266
EINECS: 245-928-9
SAFETY DATA SHEET (SDS)
Update Date: 2023-05-21 10:59:17

What is Cinepazide?

The Uses of Cinepazide

Cinepazide is an injection in the treatment of acute myocardial infarction and its effect on serum inflammatory factors.

What are the applications of Application

Cinepazide is a piperazine compound for proteomics research

Definition

ChEBI: Cinepazide is an olefinic compound. It is functionally related to a cinnamic acid.

World Health Organization (WHO)

Cinepazide, a vasodilating agent, was first introduced into medicine in 1974. It is used in the treatment of peripheral and cerebral vascular disorders. Following reports of blood dyscrasias, including agranulocytosis and thrombocytopenia, associated with the use of the drug, the Spanish Committee on Drug Surveillance has recommended its withdrawal. In other countries, the approved product information of preparations containing cinepazide has been amended to include a relevant warning on these adverse effects.

Properties of Cinepazide

Boiling point:	637.8±55.0 °C(Predicted)
Density	1.200±0.06 g/cm3(Predicted)
storage temp.	Store at -20°C
solubility	Soluble in DMSO
pka	5.22±0.10(Predicted)
CAS DataBase Reference	23887-46-9(CAS DataBase Reference)